ArticleAmerican journal of preventive cardiology2026

Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trial.

Rosalynn Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.